BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malla RR, Kumari S, Kgk D, Momin S, Nagaraju GP. Nanotheranostics: Their role in hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2020;151:102968. [DOI: 10.1016/j.critrevonc.2020.102968] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Song J, Ham J, Hong T, Song G, Lim W. Fraxetin Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Human Hepatocellular Carcinoma Cell Lines Huh7 and Hep3B. Pharmaceutics 2021;13:112. [PMID: 33477262 DOI: 10.3390/pharmaceutics13010112] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ladju RB, Ulhaq ZS, Soraya GV. Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma. World J Gastroenterol 2022; 28(2): 176-187 [DOI: 10.3748/wjg.v28.i2.176] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tian Z, Liang G, Cui K, Liang Y, Wang Q, Lv S, Cheng X, Zhang L. Insight Into the Prospects for RNAi Therapy of Cancer. Front Pharmacol 2021;12:644718. [PMID: 33796026 DOI: 10.3389/fphar.2021.644718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Azees PAA, Natarajan S, Amaechi BT, Thajuddin N, Raghavendra VB, Brindhadevi K, Pugazhendhi A. An empirical review on the risk factors, therapeutic strategies and materials at nanoscale for the treatment of oral malignancies. Process Biochemistry 2022. [DOI: 10.1016/j.procbio.2022.04.013] [Reference Citation Analysis]
5 Li D, Zhang R, Liu G, Kang Y, Wu J. Redox-Responsive Self-Assembled Nanoparticles for Cancer Therapy. Adv Healthc Mater 2020;9:e2000605. [PMID: 32893506 DOI: 10.1002/adhm.202000605] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
6 Cao H, Yang M, Yang Y, Fang J, Cui Y. PBK/TOPK promotes chemoresistance to oxaliplatin in hepatocellular carcinoma cells by regulating PTEN. Acta Biochim Biophys Sin (Shanghai) 2021;53:584-92. [PMID: 33772548 DOI: 10.1093/abbs/gmab028] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]